Medication info

Tenediar Sustained-Release Tablet 10/500 mg

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tabletTeneligliptin Ditosylate Dihydrate›18.92mg / 1 tablet
Manufacturer / importer
Genupharm Co., Ltd.
Appearance
Orange egg-shaped sustained-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202202733 · Approved 2022.07.01

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000 mg extended-release tablet once daily. Patients taking the 10/750 mg or 10/500 mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be started at the doses of teneligliptin and metformin they were previously taking. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dosage adjusted as appropriate. When administered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20 mg and extended-release metformin 2000 mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another antihyperglycemic agent. Because such a change may affect glycemic control, any change in treatment for patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
Genupharm Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used to assist patients with type 2 diabetes in controlling their blood sugar levels. It helps manage blood sugar effectively when taken together with meal therapy and exercise by combining Teneligliptin and Metformin. This aids in maintaining stable blood sugar levels and helps prevent complications of diabetes.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000 mg extended-release tablet once daily. Patients taking the 10/750 mg or 10/500 mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be started at the doses of teneligliptin and metformin they were previously taking. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dosage adjusted as appropriate. When administered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20 mg and extended-release metformin 2000 mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another antihyperglycemic agent. Because such a change may affect glycemic control, any change in treatment for patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medication is used for the treatment of diabetes and aids in controlling blood sugar levels. However, it can very rarely cause a metabolic complication called lactic acidosis, which can pose a life-threatening risk. It should not be administered to patients with impaired kidney function, heart failure, liver disease, severe infections, etc., and administration should be suspended for a certain period before and after surgery. Additionally, caution should be exercised when used in conjunction with insulin or sulfonylurea medications as the risk of hypoglycemia may increase. Patients should consult a doctor immediately if symptoms of hypoglycemia or suspected lactic acidosis appear during treatment. Regular function tests are required since this medication can affect liver and kidney functions, and special care is needed for the elderly or those with reduced kidney function. Alcohol consumption should be avoided during treatment as it can increase the risk of lactic acidosis. It is advised that pregnant women, women who may become pregnant, and nursing mothers do not take this medication. Safety in children and adolescents has not been established, so it should not be used. In case of overdose, patients should visit a hospital immediately for appropriate treatment, and in severe cases, hemodialysis may be required. Caution should be taken regarding interactions with other medications during the use of this medication, especially as there is an increased risk of hypoglycemia when combined with other blood-sugar-lowering medications. Patients should pay attention to any changes in symptoms while taking medications and consult healthcare professionals immediately if any unusual symptoms occur.

Side effects

Severe lactic acidosis, severe hypoglycemia, hypoglycemia, constipation, bowel obstruction, liver dysfunction, interstitial pneumonia, similar to pemphigus, acute pancreatitis, dizziness, abdominal distension, abdominal discomfort, nausea, abdominal pain, bloating, stomatitis, gastric polyps, colonic polyps, duodenal ulcers, gastroesophageal reflux, diarrhea, loss of appetite, elevated amylase, elevated lipase, increased AST (GOT), increased ALT (GPT), elevated GGT, increased ALP, proteinuria, ketonuria, potential hematuria, eczema, rash, itching, allergic dermatitis, arthralgia, elevated CK (CPK), increased serum potassium levels, malaise, allergic rhinitis, increased serum uric acid, peripheral edema, shingles, limb pain, upper abdominal pain, gastritis, upper respiratory infection, tremor, headache, weakness, hunger, fatigue, facial edema, dyspepsia, nausea, viral upper respiratory infection, rhinitis, cold sweat, diabetic retinopathy, decreased vision, cough, pulmonary congestion, dyspnea, drug overdose, benign prostatic hyperplasia, headache, diarrhea, chronic gastritis, irritable bowel syndrome, fatigue, cerebral infarction, hyperglycemia, liver biopsy, neutropenia, abnormal blood sugar, increased blood sugar, increased blood pressure, hepatic coma, lumbar spinal canal stenosis, intervertebral disc herniation of the spine, intervertebral disc disorder, spinal ligament ossification, foraminal stenosis of the spine, rotator cuff syndrome, bladder mass, ureterolithiasis, urinary stones, coronary artery disease, unstable angina, gastroesophageal reflux disease, gastric polyps, gastritis, biliary obstruction, chronic cholecystitis, soft tissue infection, pneumonia, cataracts, depression, iliac artery stenosis, vertigo, benign prostatic hyperplasia, knee surgery, dizziness, diabetic neuropathy, sensory abnormalities, headache, muscle weakness, lumbar pain, limb pain, lumbar spinal canal stenosis, tendinitis, cervical pain, bone pain, osteoarthritis, osteoporosis, muscle spasm, foot deformity, hypertrophic osteoarthritis, bursitis, spinal osteoarthritis, intervertebral disc herniation of the spine, intervertebral disc disorder, spinal ligament ossification, foraminal stenosis of the spine, postmenopausal osteoporosis, rotator cuff syndrome, shingles, upper respiratory infection, gastroenteritis, chronic sinusitis, folliculitis, cystitis, urinary tract infection, pharyngitis, streptococcal infection, athlete's foot, subcutaneous abscess, Helicobacter gastritis, vomiting, chronic gastritis, upper abdominal pain, odontalgia, anal-rectal discomfort, acquired mixed hyperlipidemia, hypertriglyceridemia, vitamin D deficiency, abnormal weight gain, essential hypertension, orthostatic hypotension, white coat hypertension, hemorrhage, increased blood sugar, abnormal sputum, toxic hepatitis, non-alcoholic fatty liver disease, alcoholic liver disease, eyelid injury, ligament sprain, lip injury, contusion, urticaria, glaucoma, blurred vision, age-related macular degeneration, hyperthyroidism, hyperparathyroidism, coronary artery disease, unstable angina, angina, otalgia, vertigo, iron deficiency anemia, food allergy, pressure sore ulcer, hearing loss, endolymphatic hydrops, ovarian cysts, vulvar pruritus, menopausal symptoms

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture and kept at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness for a longer duration.

Appearance and packaging

Appearance

Orange egg-shaped sustained-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.